note that daily dosing is only for the activation phase of the GLOW protocol (weeks 1-4) , decreasing to 5x per week for the remodeling phase (weeks 5-8), and further reduced to 2-3x per week during maintenance (weeks 9-12)
Withdraw the medication Once the needle is in the vial and the air has been released from the syringe, its time to withdraw the medication
Timing Considerations The 3-minute half-life of AOD-9604 means the peptide is rapidly cleared from circulation, with peak effects occurring within the first hour post-administration
ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY
The procedure is quick, typically taking just a few minutes, and there is minimal discomfort
By adjusting the dose and infusion protocol, healthcare providers can improve treatment results for patients with B12 deficiency